Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment

Molecular fingerprints point the way to earlier cancer diagnosis and more targeted treatment

March 24, 2009

Metabolites are molecular fingerprints of what your cells are up to and Dr. Arun Sreekumar wants to know the impression made by cancer.

You've likely heard about metabolites; your physician probably screens for some known ones such as triglycerides or cholesterol at your annual physical. Scientists suspect we have about 3,000 metabolites that come from our food or are synthesized from different compounds in our bodies.




Dr. Sreekumar, a cancer researcher at the Medical College of Georgia Cancer Center, wants those screens of the blood or urine to also detect early signs of cancers such as leukemia, bladder, kidney and breast when the chance for cure is best.

He's already begun to identify metabolites that indicate not only the presence of prostate cancer, but its aggressiveness, a tool that could help tailor optimal treatment. The search began in men at risk: those with elevated prostate specific antigen, or PSA, levels. A PSA test along with a digital rectal exam is today's standard for prostate screening so physicians typically do both in men age 50 and older. But PSA levels are actually better at helping determine if prostate cancer has returned, Dr. Sreekumar says.

Elevated levels of PSA, a protein, are not always predictive of cancer, which means a lot of men get unnecessary biopsies. PSA measurements also can't distinguish between tumors that have a good outcome versus those with a poor one.

"The physician does not really have the tools in hand to really say that this tumor will spread to other organs or not." says the Georgia Cancer Coalition Distinguished Cancer Scholar. "We want to find clinical markers that supplement PSA."

Aggressiveness is a major factor in prostate cancer treatment. In fact some men with slow growing disease likely won't even need treatment. So he wants to provide a complement of biomarkers that accurately diagnose and categorize the disease then help monitor success of treatment. These early studies indicate a urine test may one day be possible to do just that.

He and colleagues at the University of Michigan reported in the Feb. 12 issue of Nature what appears to be one of the first metabolites implicated in cancer invasion. They looked at 1,126 metabolites in 262 samples taken from men with high PSA levels. They consistently found elevated levels of the amino acid sarcosine in the prostate tissues of men with cancer; levels were highest in what appeared to be the most aggressive tumors.

Sarcosine, a modified form of the amino acid glycine, was a known entity but its function was unclear. Scientists thought it might be a dumping ground for excess methyl groups needed to enable chemical changes of genes, proteins and other body components that can affect what and how much they do.

This process called methylation can be a good thing - like when it's helping an embryo develop - but when it goes badly, it can cause disease such as cancer. While sarcosine's dumping role seemed to protect from cancer, the Michigan scientists found its action actually helps induce tumors. In fact, when they added it to prostate cancer cells, the cells became more aggressive. Exactly how that process works is still under study but the findings were pretty consistent.

"When we looked at patients with metastatic disease, sarcosine levels were sky high compared to patients with localized tumors," says Dr. Sreekumar. "It's enabling invasion."

Because cancer and people are both very heterogenous, measures need to be taken in larger population samples, he says. Also, they found a small group of patients with negative biopsies and high sarcosine levels. "We don't know how many of them have missed cancer," says Dr. Sreekumar who joined the MCG faculty in February.

These are among the reasons he believes in strength in numbers. "In the real world of biomarkers, you want 100 percent sensitivity. If the patient has cancer, you want to pick it up. We need to have a kind of multiplex test where you can test for say10 different entities and have a greater confidence that what you are stating about the tumor is true. Our goal is to develop such a panel and research on sarcosine is a first step toward achieving this."

In his new position at MCG, he's looking to expand the number of metabolites known to be predictive of prostate and other cancers. In prostate cancer, he's beginning with follow up on other metabolites identified in the Michigan study in which researchers identified a total of six metabolites, including sarcosine, linked to increased tumor progression. A total of 89 metabolites were different in metastatic prostate cancer compared to localized disease.

He's excited about what metabolites will one day tell cancer physicians and patients but adds that they are just a piece of what our bodies can tell us about a potential cancer growing inside. Scientists also need to continue to look at genes expressed by tumors and the proteins expressed by those genes to get the bigger picture. "It's basically a systems approach you need to take," he says.

The young scientist has worked with all those pieces in his relatively short career. He started his postdoctoral fellowship at the University of Michigan in1999, when the ability to look at gene expression was new. With his mentor, Dr. Arul M. Chinnaiyan, director of Michigan Center for Translational Pathology, Pathology Research Informatics and Cancer Bioinformatics at Michigan, he helped develop the next step: the ability to look at expression of hundreds of proteins at a time, instead of a handful, an important advance in light of the fact that there are about 1 million proteins. Recently they were among the first to venture into the world of metabolites, which are made by proteins.

"Previous technology was looking at a cell from a narrow perspective and cells never act in isolation, proteins never act in isolation, they always form complexes, act in pathways," Dr. Sreekumar says.

His inspiration to follow those pathways is a fellow Ph.D. student who died too young and quickly of an aggressive leukemia and the fact that cancer is a leading cause of death worldwide.

Medical College of Georgia



Related Cancer Diagnosis Current Events and Cancer Diagnosis News Articles Cancer Diagnosis Current Events and Cancer Diagnosis News RSS Cancer Diagnosis Current Events and Cancer Diagnosis News RSS
For young boys with cancer, testicular tissue banking may be option to preserve fertility
For parents of children with cancer, the hopeful news is that pediatric survival rates have steadily improved for decades. Among the bad news-treatments that enable survival often cause infertility.

Intervals between lung cancer diagnosis and treatment displays a health care disparity
Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies.

Brain tumors in childhood leave a lasting mark on cognition, life status
Brain tumors in childhood cast a long shadow on survivors. The first study of the lasting impact of these tumors -- the most common solid malignancies in childhood -- shows that survivors have ongoing cognitive problems.

URI research couple's method targets cancerous tumors
Two University of Rhode Island associate professors, biophysicists Yana Reshetnyak and Oleg Andreev, have discovered a technology that can detect cancerous tumors and deliver treatment to them without the harming the healthy cells surrounding them, thereby significantly reducing side effects.

UB Study Explores How Women Make Decisions About Breast Cancer Surgery
For women just diagnosed with breast cancer, one of the important decisions confronting them is whether to have a lumpectomy or mastectomy. A diagnosis of breast cancer will affect one in every eight women in the United States.

UNC expert: Better decision support tools needed for prostate cancer screening choice
Although screening for prostate cancer with the Prostate Specific Antigen (PSA) test in men ages 50-70 can detect the cancer before it becomes symptomatic, knowing whether screening is beneficial for these men is uncertain.

More women choosing to remove healthy breast after cancer diagnosis
A new study of New York State data finds that the number of women opting for surgery to remove the healthy breast after a cancer diagnosis in one breast is rising, despite a lack of evidence that the surgery can improve survival.

Protein complex key in avoiding DNA repair mistakes, cancer
As the body creates antibodies to fight invaders, a three-protein DNA repair complex called MRN is crucial for a normal gene-shuffling process to proceed properly, University of Michigan research shows.

Physician trust, early screening reduces disparities for prostate cancer
Men who have a regular, ongoing relationship with a health care provider are more likely to receive prostate cancer screening and less likely to be diagnosed with advanced prostate cancer, regardless of their race, according to a University of North Carolina study published in the current issue of the journal Cancer.

2 reproductive factors are important predictors of death from ovarian cancer
Researchers from the Centers for Disease Control and Prevention (CDC) found that survival among women with ovarian cancer is influenced by age of menarche and total number of lifetime ovulatory cycles.
More Cancer Diagnosis Current Events and Cancer Diagnosis News Articles
Cancer Diagnosis: What to Do Next

Cancer Diagnosis: What to Do Next
by W. John Diamond (Author)

The complete guide to early detection and prevention of cancer and with proven safe and nontoxice treatments.

Breast Cancer?  But Doctor....I hate pink

Breast Cancer? But Doctor....I hate pink
by Ann Silberman

With an humor and intelligence, Ann Silberman, breast-cancer "ass-kicker," describes her life since diagnosis. She found her lump in May 2009 and was diagnosed in early September. She is sharing her journey through surgeries and chemo as they happen. A must-read for anybody who either has cancer or has a family member with this disease. Ann writes with wit and energy in her blog: Breast Cancer? But Doctor ... I hate pink.Kindle blogs are fully downloaded onto your Kindle so you can read them even when you're not wirelessly connected. And unlike RSS readers which often only provide headlines, blogs on Kindle give you full text content and images, and are updated wirelessly throughout the day.

Prostate Cancer:  Prevention, Diagnosis, and Treatment

Prostate Cancer: Prevention, Diagnosis, and Treatment

Prostate cancer is the most commonly diagnosed cancer in men in the United States. Virtually every man over 40 has cancerous growths in his prostate, although most will not die of the disease. This program focuses on what is known about preventing prostate cancer, current diagnostic techniques, and the variety of treatments available. James D. Brooks, MD, is Assistant Professor of Urology at the Stanford University School of Medicine. Dr. Brooks focuses exclusively on the treatment of prostate cancer. He is an acknowledged expert in the technique of nerve-sparing radical retropubic prostatectomy and in the surgical anatomy of the pelvis, and has carried out pioneering research on the genetic changes occurring in urological cancers. He has also published extensively on scientific and...

EARLY CANCER CONTROL DIAGNOSIS TREATMENT AMERICAN US USA SMALL VINTAGE POSTER REPRO

EARLY CANCER CONTROL DIAGNOSIS TREATMENT AMERICAN US USA SMALL VINTAGE POSTER REPRO
by WONDERFULITEMS

THIS IS A BEAUTIFUL / GREAT QUALITY REPRODUCTION VINTAGE POSTER !!! THE POSTERS ARE PRINTED ON HEAVYWEIGHT PROFESSIONAL MATTE PAPER USING **GICLEE** TECHNIQUE. THE QUALITY OF THE IMAGES IS JUST AMAZING!!! 100% SATISFACTION GUARANTEE!!! IF YOU ARE NOT SATISFIED JUST RETURN THE POSTER, NO QUESTIONS ASKED!!! IMAGE SIZE IS 12" X 16" INCHES - PAPER SIZE IS 15" X 18" INCHES. THIS POSTER WILL MAKE A FANTASTIC ADDITION TO THE HOME DÉCOR!!! ***HIGH QUALITY POSTER FOR DISCERNING CLIENTES!!!!!***

Cancer Man

Cancer Man
Starring: Charles Baker, Frederic Doss, Matt L. Jones, Aaron Paul, Steven Michael Quezada
Also With: Sony Home Entertainment (Producer)



Living and Laughing with Cancer - A Comedian's Journey (From Diagnosis to Recovery with Cancer Survivor Dave Fitzgerald)

Living and Laughing with Cancer - A Comedian's Journey (From Diagnosis to Recovery with Cancer Survivor Dave Fitzgerald)
Also With: Dave Fitzgerald (Primary Contributor)

Outfitted with only radical surgery and his keen sense of humor, internationally known comedian Dave Fitzgerald not only survived cancer, he endured his ordeal with a big smile! We have all heard that laughter is the best medicine, but where do you get the healing prescription? Share this poignant video with a loved one, friend, or business associate you know whose life has been turned upside down with a diagnosis of cancer or other life-threatening condition. This inside story will help them deal with their new reality as it captures the essence of what it takes to survive such a challenge.

Diagnosis Cancer

Diagnosis Cancer
Stuart Turner (Primary Contributor)



Cancer Pain: Assessment, Diagnosis, And Management

Cancer Pain: Assessment, Diagnosis, And Management
by Lippincott Williams & Wilkins

Cancer Pain: Assessment, Diagnosis, and Management : Cancer Pain: Assessment, Diagnosis, and Management Pub Date: January 2010 Product Type: Print Author/s: Dermot R Fitzgibbon MB, BCh; John D Loeser MD This book provides, in a single cohesive source, all the information a health care professional needs to diagnose and select appropriate treatments for the patient with pain associated with cancer. Cancer Pain: Assessment, Diagnosis, and Management is clinically oriented and comprehensively addresses all the issues surrounding modern cancer pain management. The authors provide detailed information on common but difficult to treat cancer pain scenarios. Coverage includes state-of-the-art information on treatment options and discussions of the impact of radiation,...

Cancer Research / Testing Cells

Cancer Research / Testing Cells
Directed By: Rex Barnett



Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival

Prostate and Cancer: A Family Guide to Diagnosis, Treatment, and Survival
by Sheldon Marks MD (Author)

Prostate cancer is one of the most common cancers affecting American men, with over 186,000 new cases diagnosed in the United States annually; 1 in 6 men will be diagnosed with prostate cancer during his lifetime. Renowned prostate cancer specialist Sheldon Marks offers the definitive guide for men concerned about or diagnosed with prostate cancer, and for their families.

Since the third edition (2003), there have been significant changes in treatment and resources. Working with Dr. Judd Moul, the Chairman of Urology at Duke and one of the world’s top experts on prostate cancer, Marks provides the most up-to- date information on diagnosis, treatment, and common questions.

© 2009 BrightSurf.com